Measured Wealth Private Client Group, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1720235 PORTSMOUTH, NH

Position in GILD

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$288,774

+$34,457 QoQ

Shares Held

2,072

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Measured Wealth Private Client Group, LLC holds $3,974,731 across 13 Drug Manufacturers - General names. GILD ranks #6 (7.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	25,075	$1,520,798
2	JNJ	Johnson & Johnson	3,336	$815,451
3	ABBV	AbbVie Inc.	2,142	$465,863
4	AMGN	Amgen Inc	905	$318,424
5	MRK	Merck & Co., Inc.	2,518	$302,890
6	GILD	Gilead Sciences, Inc. This page	2,072	$288,774
7	LLY	ELI LILLY & Co	114	$104,853
8	PFE	Pfizer Inc	2,283	$64,106

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$288,774	2,072	0.0%	Shares	Sole	2026-05-13
2025-12-31	$254,317	2,072	0.0%	Shares	Sole	2026-02-10
2025-09-30	$229,992	2,072	0.0%	Shares	Sole	2025-11-14
2025-06-30	$229,722	2,072	-0.5%	Shares	Sole	2025-08-13
2025-03-31	$233,400	2,083	-9.9%	Shares	Sole	2025-05-12
2024-12-31	$213,651	2,313	-5.6%	Shares	Sole	2025-01-27
2024-09-30	$205,408	2,450	-50.8%	Shares	Sole	2024-10-28
2024-03-31	$364,565	4,977	-10.5%	Shares	Sole	2024-04-18
2023-12-31	$450,577	5,562	-60.1%	Shares	Sole	2024-02-06
2023-09-30	$1,043,989	13,931	+11.9%	Shares	Sole	2023-10-18
2023-06-30	$959,752	12,453	+18.3%	Shares	Sole	2023-07-20
2023-03-31	$873,674	10,530	+21.4%	Shares	Sole	2023-05-01
2022-12-31	$744,748	8,675	+80.3%	Shares	Sole	2023-01-23
2022-09-30	$296,790	4,811	—	Shares	Sole	2022-10-27
No filing history on record for this holder in this stock.